Divisas / CVAC
CVAC: CureVac N.V
5.46
USD
0.03
(0.55%)
El tipo de cambio de CVAC de hoy ha cambiado un 0.55%. En este caso, el precio mínimo en el mercado ha alcanzado 5.41, mientras que el máximo ha alcanzado 5.47.
Siga la dinámica de la pareja de divisas CureVac N.V. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CVAC News
- Investing Deutsche Bank bearish on European pharma stocks into Q2 amid political headwinds
- Benzinga This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Adaptimmune Therapeutics (NASDAQ:ADAP), ASML Holding (NASDAQ:ASML)
- Investing CureVac stock downgraded to neutral by UBS after BioNTech acquisition
- Investing CureVac shareholders approve management changes and auditor
- Seeking Alpha M&A Watch: A String Of Hot IPOs Could Spark Second-Half Dealmaking
- Benzinga This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - CureVac (NASDAQ:CVAC), Dayforce (NYSE:DAY)
- Investing Jefferies cuts CureVac stock rating to hold on BioNTech acquisition
- Seeking Alpha BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer (BNTX)
- Investing Oracle, GameStop Lead Market Cap Stock Movers on Thursday
- TipRanks Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories - TipRanks.com
- Benzinga Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results - CureVac (NASDAQ:CVAC), Helius Medical Tech (NASDAQ:HSDT)
- TipRanks M&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal - TipRanks.com
- Benzinga BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - CureVac (NASDAQ:CVAC), Novavax (NASDAQ:NVAX)
- Benzinga CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday - CureVac (NASDAQ:CVAC), DeFi Development (NASDAQ:DFDV)
- Investing Oracle and GameStop Headline Market Cap Stock Movers on Thursday
- Investing BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
- Investing Oracle and CureVac rise premarket; Boeing and GameStop fall
- Investing CureVac stock soars about 30% after BioNTech agrees to acquire co
- MarketWatch Gundlach says gold is no longer for lunatics as the bond king says wait to buy the 30-year
- Investing BioNTech to acquire CureVac in $1.25 billion all-stock deal
- Benzinga Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort - CureVac (NASDAQ:CVAC), Moderna (NASDAQ:MRNA)
- Investing CureVac stock maintains $10 target from JMP on GBM vaccine outlook
- Benzinga CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction - CureVac (NASDAQ:CVAC)
- Investing CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
Rango diario
5.41
5.47
Rango anual
2.37
5.72
- Cierres anteriores
- 5.45
- Open
- 5.43
- Bid
- 5.46
- Ask
- 5.76
- Low
- 5.41
- High
- 5.47
- Volumen
- 1.778 K
- Cambio diario
- 0.55%
- Cambio mensual
- 1.68%
- Cambio a 6 meses
- 50.00%
- Cambio anual
- 45.99%
13 julio, domingo